A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
Clinical trial NCT03661320 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03661320
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-06
- Primary completion
- 2026-02-16
- Enrollment
- 855
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.